FAQs

Zymeworks shares are traded on NASDAQ under the ticker symbol ZYME.

Our shares began trading on April 28, 2017.

114 East 4th Avenue, Suite 800, Vancouver, BC V5T 1G4

You can view the Company’s Board of Directors by visiting the Board of Directors page on the website.

You can view the Company’s management team by visiting the Management page on the website.

The Company’s fiscal year end is December 31.

The Company’s independent auditors are KPMG LLP.

The Company’s transfer agent is Computershare.

You can contact Computershare via their website: www.computershare.com

Written requests by regular mail can be made to:

U.S. Investors:
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
United States of America

Canadian Investors:
Computershare Investor Services
100 University Ave., 8th Floor, North Tower
Toronto, Ontario M5J 2Y1 Canada
Telephone inquiries:
1-800-564-6253 (toll free in Canada and the United States) between the hours of 8:30 a.m. and 8:00 p.m. Eastern Time or 514-982-7555 (international direct dial).

Email: web.queries@computershare.com

The Company does not currently have a direct stock purchase plan.

The Company’s SEC filing can be accessed on the Financial Documents page of the investor relations portion of its website or can be accessed directly from the SEC’s website at www.sec.gov.

You can submit questions to the Zymeworks investor relations team by contacting ir@zymeworks.com or by submitting a request via the Contact Us page.